Coegin Pharma Investor Relations Material
Latest events
Status Update
Coegin Pharma
Q1 2025
22 May, 2025
Q4 2024
27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Coegin Pharma
Access all reports
Coegin Pharma AB is a Sweden-based biotechnology company focused on developing innovative therapies for inflammatory-driven diseases. The company leverages its expertise in molecular targeting to develop pharmaceutical candidates addressing conditions such as cancer, fibrosis, and chronic inflammation. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
COEGIN
Country
🇸🇪 Sweden